About this Journal Submit a Manuscript Table of Contents
International Journal of Rheumatology
Volume 2012 (2012), Article ID 839425, 10 pages
http://dx.doi.org/10.1155/2012/839425
Review Article

Measuring Disease Activity in Psoriatic Arthritis

Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Received 3 September 2012; Accepted 17 November 2012

Academic Editor: Zahi Touma

Copyright © 2012 Priscilla C. H. Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. D. Gladman, “Consensus on a core set of domains for psoriatic arthritis,” The Journal of Rheumatology, vol. 34, no. 5, pp. 1167–1170, 2007.
  2. J. M. H. Moll and V. Wright, “Psoriatic arthritis,” Seminars in Arthritis and Rheumatism, vol. 3, no. 1, pp. 55–78, 1973. View at Publisher · View at Google Scholar · View at Scopus
  3. Cooperating Clinics Committee of The American Rheumatism Association, “A seven-day variability study of 488 patients with peripheral rheumatoid arthritis,” Arthritis and Rheumatism, vol. 8, pp. 302–334, 1965. View at Scopus
  4. D. D. Gladman, P. J. Mease, P. Healy, et al., “Outcome measures in PsA,” The Journal of Rheumatology, vol. 34, no. 5, pp. 1159–1166, 2007.
  5. D. D. Gladman, R. J. Cook, C. Schentag et al., “The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada,” The Journal of Rheumatology, vol. 31, no. 6, pp. 1126–1131, 2004. View at Scopus
  6. D. D. Gladman, V. Farewell, D. Buskila et al., “Reliability of measurements of active and damaged joints in psoriatic arthritis,” The Journal of Rheumatology, vol. 17, no. 1, pp. 62–64, 1990. View at Scopus
  7. D. D. Gladman, R. D. Inman, R. J. Cook et al., “International spondyloarthritis interobserver reliability exercise—the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis,” The Journal of Rheumatology, vol. 34, no. 8, pp. 1740–1745, 2007. View at Scopus
  8. E. Puzenat, V. Bronsard, S. Prey et al., “What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature,” Journal of the European Academy of Dermatology and Venereology, vol. 24, supplement 2, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Ramsay and C. M. Lawrence, “Measurement of involved surface area in patients with psoriasis,” British Journal of Dermatology, vol. 124, no. 6, pp. 565–570, 1991. View at Scopus
  10. T. Fredriksson and U. Pettersson, “Severe psoriasis—oral therapy with a new retinoid,” Dermatologica, vol. 157, no. 4, pp. 238–244, 1978. View at Scopus
  11. R. G. Langley and C. N. Ellis, “Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment,” Journal of the American Academy of Dermatology, vol. 51, no. 4, pp. 563–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. R. Feldman, A. B. Fleischer Jr., D. M. Reboussin et al., “The self-administered psoriasis area and severity index is valid and reliable,” The Journal of Investigative Dermatology, vol. 106, no. 1, pp. 183–186, 1996. View at Scopus
  13. B. Kirby, D. G. Fortune, M. Bhushan, R. J. G. Chalmers, and C. E. M. Griffiths, “The salford psoriasis index: an holistic measure of psoriasis severity,” British Journal of Dermatology, vol. 142, no. 4, pp. 728–732, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Berth-Jones, K. Grotzinger, C. Rainville et al., “A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: psoriasis area and severity index, physician's global assessment and lattice system physician's global assessment,” British Journal of Dermatology, vol. 155, no. 4, pp. 707–713, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Paul, P. A. Gourraud, V. Bronsard et al., “Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists,” Journal of the European Academy of Dermatology and Venereology, vol. 24, supplement 2, pp. 2–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Sampogna, F. Sera, D. Abeni, and IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators, “Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis,” The Journal of Investigative Dermatology, vol. 122, no. 3, pp. 602–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. I. Spuls, L. L. A. Lecluse, M. L. N. F. Poulsen, J. D. Bos, R. S. Stern, and T. Nijsten, “How good are clinical severity and outcome measures for psoriasis: quantitative evaluation in a systematic review,” The Journal of Investigative Dermatology, vol. 130, no. 4, pp. 933–943, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Helliwell, J. Firth, G. H. Ibrahim, R. D. Melsom, I. Shah, and D. E. Turner, “Development of an assessment tool for dactylitis in patients with psoriatic arthritis,” The Journal of Rheumatology, vol. 32, no. 9, pp. 1745–1750, 2005. View at Scopus
  19. J. E. Brockbank, M. Stein, C. T. Schentag, and D. D. Gladman, “Dactylitis in psoriatic arthritis: a marker for disease severity?” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 188–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Chandran, A. Gottlieb, R. J. Cook et al., “International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis,” Arthritis Care and Research, vol. 61, no. 9, pp. 1235–1242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Fernández-Sueiro, A. Willisch, S. Pértega-DÍAZ et al., “Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis,” Arthritis Care and Research, vol. 61, no. 3, pp. 386–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. D. Gladman and V. Chandran, “Observational cohort studies: lessons learnt from the University of Toronto psoriatic arthritis program,” Rheumatology, vol. 50, no. 1, pp. 25–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Mander, J. M. Simpson, A. McLellan, D. Walker, J. A. Goodacre, and W. C. Dick, “Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 46, no. 3, pp. 197–202, 1987. View at Scopus
  24. G. R. Auleley, K. Benbouazza, A. Spoorenberg et al., “Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis,” Arthritis Care and Research, vol. 47, no. 6, pp. 582–587, 2002. View at Scopus
  25. D. van der Heijde, B. Dijkmans, P. Geusens et al., “Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT),” Arthritis and Rheumatism, vol. 52, no. 2, pp. 582–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Heuft-Dorenbosch, A. Spoorenberg, A. van Tubergen et al., “Assessment of enthesitis in ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 62, no. 2, pp. 127–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Braun, J. Brandt, J. Listing et al., “Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial,” The Lancet, vol. 359, no. 9313, pp. 1187–1193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. W. P. Maksymowych, C. Mallon, S. Morrow et al., “Development and validation of the spondyloarthritis research consortium of Canada (SPARCC) enthesitis index,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 948–953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. D'Agostino, R. Said-Nahal, C. Hacquard-Bouder, J. L. Brasseur, M. Dougados, and M. Breban, “Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study,” Arthritis and Rheumatism, vol. 48, no. 2, pp. 523–533, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. R. G. W. Lambert, S. S. Dhillon, G. S. Jhangri et al., “High prevalence of symptomatic enthesopathy of the shoulder in ankylosing spondylitis: deltoid origin involvement constitutes a hallmark of disease,” Arthritis Care and Research, vol. 51, no. 5, pp. 681–690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. J. Healy and P. S. Helliwell, “Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis,” Arthritis Care and Research, vol. 59, no. 5, pp. 686–691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. L. C. Coates and P. S. Helliwell, “Disease measurement—enthesitis, skin, nails, spine and dactylitis,” Best Practice and Research Clinical Rheumatology, vol. 24, no. 5, pp. 659–670, 2010. View at Publisher · View at Google Scholar
  33. E. M. Farber and L. Nall, “Nail psoriasis,” Cutis, vol. 50, no. 3, pp. 174–178, 1992. View at Scopus
  34. O. Elkayam, J. Ophir, M. Yaron, and D. Caspi, “Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution,” Clinical Rheumatology, vol. 19, no. 4, pp. 301–305, 2000. View at Scopus
  35. L. Williamson, N. Dalbeth, J. L. Dockerty, B. C. Gee, R. Weatherall, and B. P. Wordsworth, “Extended report: nail disease in psoriatic arthritis—clinically important, potentially treatable and often overlooked,” Rheumatology, vol. 43, no. 6, pp. 790–794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Rich and R. K. Scher, “Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis,” Journal of the American Academy of Dermatology, vol. 49, no. 2, pp. 206–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. E. Cassell, J. D. Bieber, P. Rich et al., “The modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis,” The Journal of Rheumatology, vol. 34, no. 1, pp. 123–129, 2007. View at Scopus
  38. D. D. Gladman, B. Brubacher, D. Buskila, P. Langevitz, and V. T. Farewell, “Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study,” Clinical and Investigative Medicine, vol. 15, no. 4, pp. 371–375, 1992. View at Scopus
  39. D. D. Gladman, R. Shuckett, and M. L. Russell, “Psoriatic arthritis (PSA)—an analysis of 220 patients,” Quarterly Journal of Medicine, vol. 62, no. 238, pp. 127–141, 1987. View at Scopus
  40. J. C. T. Alonso, A. R. Perez, J. M. A. Castrillo, J. B. Garcia, J. L. R. Noriega, and C. L. Larrea, “Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients,” British Journal of Rheumatology, vol. 30, no. 4, pp. 245–250, 1991. View at Scopus
  41. D. Veale, S. Rogers, and O. FitzGerald, “Classification of clinical subsets in psoriatic arthritis,” British Journal of Rheumatology, vol. 33, no. 2, pp. 133–138, 1994. View at Scopus
  42. S. Garrett, T. Jenkinson, L. G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin, “A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index,” The Journal of Rheumatology, vol. 21, no. 12, pp. 2286–2291, 1994. View at Scopus
  43. A. Calin, S. Garrett, H. Whitelock, J. O'Hea, P. Mallorie, and T. Jenkinson, “A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index,” The Journal of Rheumatology, vol. 21, no. 12, pp. 2281–2285, 1994. View at Scopus
  44. T. R. Jenkinson, P. A. Mallorie, H. C. Whitelock, L. G. Kennedy, S. L. Garrett, and A. Calin, “Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index,” The Journal of Rheumatology, vol. 21, no. 9, pp. 1694–1698, 1994. View at Scopus
  45. D. D. Gladman, R. D. Inman, R. J. Cook et al., “International spondyloarthritis interobserver reliability exercise—the INSPIRE study: I. Assessment of spinal measures,” The Journal of Rheumatology, vol. 34, no. 8, pp. 1733–1739, 2007. View at Scopus
  46. W. J. Taylor and A. A. Harrison, “Could the bath ankylosing spondylitis disease activity index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?” Arthritis Care and Research, vol. 51, no. 3, pp. 311–315, 2004. View at Scopus
  47. J. L. Fernández-Sueiro, A. Willisch, S. Pértega-Díaz et al., “Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis,” Arthritis Care and Research, vol. 62, no. 1, pp. 78–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Cauli, D. D. Gladman, A. Mathieu et al., “Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study,” The Journal of Rheumatology, vol. 38, no. 5, pp. 898–903, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, “Measurement of patient outcome in arthritis,” Arthritis and Rheumatism, vol. 23, no. 2, pp. 137–145, 1980. View at Scopus
  50. L. H. Daltroy, M. G. Larson, W. N. Roberts, and M. H. Liang, “A modification of the health assessment questionnaire for the spondyloarthropathie,” The Journal of Rheumatology, vol. 17, no. 7, pp. 946–950, 1990. View at Scopus
  51. J. A. Husted, D. D. Gladman, J. A. Long, and V. T. Farewell, “A modified version of the health assessment questionnaire (HAQ) for psoriatic arthritis,” Clinical and Experimental Rheumatology, vol. 13, no. 4, pp. 439–443, 1995. View at Scopus
  52. M. G. Blackmore, D. D. Gladman, J. Husted, J. A. Long, and V. T. Farewell, “Measuring health status in psoriatic arthritis: the health assessment questionnaire and its modification,” The Journal of Rheumatology, vol. 22, no. 5, pp. 886–893, 1995. View at Scopus
  53. J. E. Ware Jr. and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Scopus
  54. J. A. Husted, D. D. Gladman, J. A. Long, V. T. Farewell, and R. J. Cook, “Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis,” The Journal of Rheumatology, vol. 24, no. 3, pp. 511–517, 1997. View at Scopus
  55. S. P. McKenna, L. C. Doward, D. Whalley, A. Tennant, P. Emery, and D. J. Veale, “Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 63, no. 2, pp. 162–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Y. Finlay and G. K. Khan, “Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use,” Clinical and Experimental Dermatology, vol. 19, no. 3, pp. 210–216, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Mease, “Psoriatic arthritis: update on pathophysiology, assessment and management,” Annals of the Rheumatic Diseases, vol. 70, no. 1, pp. i77–i84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. P. J. Mease and C. E. Antoni, “Psoriatic arthritis treatment: biological response modifiers,” Annals of the Rheumatic Diseases, vol. 64, supplement 2, pp. ii78–ii82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. P. J. Mease, “Psoriatic arthritis: pharmacotherapy update,” Current Rheumatology Reports, vol. 12, no. 2, pp. 272–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. The EuroQol Group, “EuroQol—a new facility for the measurement of health-related quality of life,” Health Policy, vol. 16, no. 3, pp. 199–208, 1990. View at Publisher · View at Google Scholar · View at Scopus
  61. L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, “The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus,” Archives of Neurology, vol. 46, no. 10, pp. 1121–1123, 1989. View at Scopus
  62. D. Cella, J. S. Lai, C. H. Chang, A. Peterman, and M. Slavin, “Fatigue in cancer patients compared with fatigue in the general United States population,” Cancer, vol. 94, no. 2, pp. 528–538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. B. L. Belza, C. J. Henke, E. H. Yelin, W. V. Epstein, and C. L. Gilliss, “Correlates of fatigue in older adults with rheumatoid arthritis,” Nursing Research, vol. 42, no. 2, pp. 93–99, 1993. View at Scopus
  64. E. M. A. Smets, B. Garssen, B. Bonke, and J. C. J. M. de Haes, “The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue,” Journal of Psychosomatic Research, vol. 39, no. 3, pp. 315–325, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. S. J. Bowman, D. A. Booth, R. G. Platts, and The UK Sjogren’s Interest Group, “Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool,” Rheumatology, vol. 43, no. 6, pp. 758–764, 2004. View at Publisher · View at Google Scholar
  66. F. Wolfe, D. J. Hawley, and K. Wilson, “The prevalence and meaning of fatigue in rheumatic disease,” The Journal of Rheumatology, vol. 23, no. 8, pp. 1407–1417, 1996. View at Scopus
  67. C. T. Schentag, J. Cichon, A. MacKinnon, D. D. Gladmann, and M. B. Urowitz, “Validation and normative data for the 0-10 point scale version of the fatigue severity scale (FSS),” Arthritis and Rheumatism, vol. 43, article S177, 2000.
  68. V. Chandran, S. Bhella, C. Schentag, and D. D. Gladman, “Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 7, pp. 936–939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Eberl, A. Studnicka-Benke, H. Hitzelhammer, F. Gschnait, and J. S. Smolen, “Development of a disease activity index for the assessment of reactive arthritis (DAREA),” Rheumatology, vol. 39, no. 2, pp. 148–155, 2000. View at Scopus
  70. V. P. Nell-Duxneuner, T. A. Stamm, K. P. Machold, S. Pflugbeil, D. Aletaha, and J. S. Smolen, “Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 546–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Schoels, D. Aletaha, J. Funovits, A. Kavanaugh, D. Baker, and J. S. Smolen, “Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1441–1447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. D. D. Gladman, B. D. M. Tom, P. J. Mease, and V. T. Farewell, “Informing response criteria for psoriatic arthritis. I: discrimination models based on data from 3 anti-tumor necrosis factor randomized studies,” The Journal of Rheumatology, vol. 37, no. 9, pp. 1892–1897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. D. D. Gladman, B. D. M. Tom, P. J. Mease, and V. T. Farewell, “Informing response criteria for psoriatic arthritis (PsA). II: further considerations and a proposal—the PsA joint activity index,” The Journal of Rheumatology, vol. 37, no. 12, pp. 2559–2565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Mumtaz, P. Gallagher, B. Kirby et al., “Development of a preliminary composite disease activity index in psoriatic arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 2, pp. 272–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. O. FitzGerald, P. Helliwell, A. Mumtaz, L. Coates, R. Pedersen, and C. Molta, “Application of composite disease activity scores in psoriatic arthritis to the PRESTA dataset,” Annals of the Rheumatic Diseases, vol. 71, no. 3, pp. 358–362, 2012.
  76. P. S. Helliwell, O. FitzGerald, J. Fransen, et al., “The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project),” Annals of the Rheumatic Diseases. In press. View at Publisher · View at Google Scholar
  77. P. S. Helliwell, O. FitzGerald, P. J. Mease, and D. D. Gladman, “GRAPPA responder index project (GRACE): a report from the GRAPPA, 2011 Annual Meeting,” The Journal of Rheumatology, vol. 39, no. 11, pp. 2196–2197, 2012. View at Publisher · View at Google Scholar
  78. L. C. Coates, J. Fransen, and P. S. Helliwell, “Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 48–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. L. C. Coates, R. Cook, K. A. Lee, V. Chandran, and D. D. Gladman, “Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort,” Arthritis Care and Research, vol. 62, no. 7, pp. 970–976, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. L. C. Coates and P. S. Helliwell, “Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data,” Arthritis Care and Research, vol. 62, no. 7, pp. 965–969, 2010. View at Publisher · View at Google Scholar · View at Scopus